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larger areas of tissue. Tumour immunology
is covered in depth, and almost half the
book is devoted to immunotherapy. The
description of the experimental basis for this
therapy is logical, critical and provides the
best and most balanced overview of this
subject that I have read. The trials and tribu-
lations of the more recent attempts at im-
miunotherapy of human cancer are precisely
reported in the last chapter. This cannot be
faulted as a review but I was disappointed by
the last section "Present position and future
prospects," which is vague and indecisive.
Sadly, I suppose this reflects the state of the
subject, for if the facts permitted a grand
synthesis, surely Professor Woodruff would
be the man to make it.
P. ALEXANDER
Transplantation Today Volume 6. A. P.
MONACO, M. L. WOOD & F. T. RAPAPORT.
(1981) New York: Grune and Stratton.
1305 pp. $37.50 net.
The main impediment to successful tissue
transplantation is immunological rejection. In
the case of marrow transplants it is the
recipient who may elicit an immune response
in the marrow cells of the donor, leading to
graft-versus-host disease. The main objec-
tives of current transplantation research are
to avoid inducing rejection, either by care-
fully matching donor and recipient HLA
antigens, orbythe use ofimmuno-suppressive
drugs. "Transplantation Today" Volume 6
is a collection of papers delivered at the
Eighth International Congress of the Trans-
plantation Society, held in Boston, U.S.A. in
1980, concerned largely with the conceptual
and practical problems presented by re-
jection. Because histocompatibility research
is continuously defining more tissue antigens
however, it may never be possible to achieve
the goal of donor-recipient matching. Some
workers, believe that this may not be
necessary, since few antigens may be crucial
in triggering rejection. This explains the
relatively large number of contributions re-
lating to the HLA-D/DR antigen system.
To the clinician charged with coping with the
daily problem of rejection, it is often necess-
ary to use more drastic means to modify
immunity, achieved by a selection of gener-
ally highly effective immuno-suppressive
drugs. However, the long-term use of these
drugs has its penalities. One of these is the
higher incidence of malignant disease in
transplant recipients than in normal indi-
viduals. Penn suggests that the incidence of
non-Hodgkin's lymphoma is 45-100-fold
higher than in the general population.
Clearly, these alarming figures have to be
set against the potential benefits which
accrue from transplantation. It is a subject
that might have warranted more space in this
volume. The diversity of histocompatibility
research generated by finding that the genes
coding for transplantation antigens are in-
volved in, or associated with the control of
immunity has created something of a
dilemma that clearly emerges in this volume.
In attempting to present the current
status of transplantation research is it neces-
sary to cover the much wider field ofImmuno-
biology? In addition, many papers are not
presenting new results, though they are
short enough in most cases for this not to
matter too much. But the weight of numbers
obscures more fundamental contributions.
There is a good argument for reducing many
of the papers to abstract lengths.
G. M. TAYLOR
Hodgkin's Disease and the Lymphomas
Vol. 4. Ed. C. R. TAYLOR. (1981) Edin-
burgh: Churchill Livingstone. 377 pp.
£24.00 net.
This is the 4th Annual Review ofHodgkin's
disease and Lymphomas by Clive Taylor, and
as usual with his reviews, they are a pleasure
to read, with perhaps more attention than
might have been expected to making the
English intelligible and enjoyable.
It is perhaps inevitable that this review
should concentrate mainly on non-Hodgkin's
lymphoma, and in particular, on the con-
siderable turmoil in the histological classifi-
cation of non-Hodgkin's lymphoma which
exists at the moment. In this respect, the
book fulfils an important and timely role in
summarizing and gathering together the
wealth of information which has recently
been published about the pathological and
immunological classification of lymphomas.
Dr Taylor and his co-authors wisely do not
come to any definite conclusions on which
classification is superior, though, because the
book has been written and compiled in
California at Professor Luke's centre, con-